Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract 5310: Prognostic and predictive biomarkers of clinical response to Bevacizumab in recurrent WHO grade 3 malignant glioma patients

Anders Toft, Thomas Urup, Kirsten Grunnet, Ib J. Christensen, Signe R. Michaelsen, Helle Broholm, Vibeke A. Larsen, Michael Kosteljanetz, Ulrik Lassen, Hans S. Poulsen

Cancer Res (2015) 75 (15_Supplement): 5310.

DOI: https://doi.org/10.1158/1538-7445.AM2015-5310

Published: 01 August 2015

View article

Journal Articles

Abstract 4170: The role of VEGF-C for cell viability, tumor growth and bevacizumab resistance in glioblastoma multiforme

Signe R. Michaelsen, Mette K. Nedergaard, Thomas Urup, Mette Villingshoej, Andreas Kjaer, Lara Perryman, Janine T. Erler, Ulrik Lassen, Hans S. Poulsen

Cancer Res (2015) 75 (15_Supplement): 4170.

DOI: https://doi.org/10.1158/1538-7445.AM2015-4170

Published: 01 August 2015

View article

Journal Articles

Abstract 3126: Insulinoma-associated 1 is a key transcriptional regulator of growth and survival-promoting pathways in small cell lung cancer.

Camilla L. Christensen, Takeshi Shimamura, Esra A. Akbay, Signe R. Michaelsen, Hans S. Poulsen, Kwok-kin Wong

Cancer Res (2013) 73 (8_Supplement): 3126.

DOI: https://doi.org/10.1158/1538-7445.AM2013-3126

Published: 15 April 2013

View article

Journal Articles

Abstract 832: Suicide gene therapy is effective for treating chemo-resistant small cell lung cancer cells

Signe R. Michaelsen, Camilla L. Christensen, Maxwell Sehested, Frederik Cramer, Thomas T. Poulsen, Hans S. Poulsen

Cancer Res (2012) 72 (8_Supplement): 832.

DOI: https://doi.org/10.1158/1538-7445.AM2012-832

Published: 15 April 2012

View article

Journal Articles

Abstract 3701: Phase II study of BIBF1120 in recurrent glioblastoma multiforme

Ulrik Lassen, Morten Mau-Soerensen, Aida Muhic, Eva Ehrnrooth, Hans S. Poulsen

Cancer Res (2012) 72 (8_Supplement): 3701.

DOI: https://doi.org/10.1158/1538-7445.AM2012-3701

Published: 15 April 2012

View article

Journal Articles

Abstract 2732: Internalization of the dual-specific immunotoxin D2C7-(scdsFv)-PE38KDEL in malignant glioma cell lines

Chris J. Hedegaard, Charles N. Pegram, Darell D. Bigner, Hans S. Poulsen

Cancer Res (2012) 72 (8_Supplement): 2732.

DOI: https://doi.org/10.1158/1538-7445.AM2012-2732

Published: 15 April 2012

View article

Journal Articles

Abstract 3339: The role of active Notch signaling in glioblastoma neurosphere cultures

Karina Kristoffersen, Mette Villingshøj, Marie-Thérése Stockhausen, Hans S. Poulsen

Cancer Res (2012) 72 (8_Supplement): 3339.

DOI: https://doi.org/10.1158/1538-7445.AM2012-3339

Published: 15 April 2012

View article

Journal Articles

EGFR and EGFRvIII induces expression of the proangiogenic receptor EphA2 in cancer cells

Alice Bjerregaard, Mikkel W. Pedersen, Nina Pedersen, Hans S. Poulsen

Cancer Res (2006) 66 (8_Supplement): 20–21.

Published: 15 April 2006

View article

Journal Articles

The human Achaete Scute Homolog 1 promoter - a candidate for transcriptionally regulated gene therapy of small cell lung cancer

Thomas T. Poulsen, Nina Pedersen, Mikkel W. Pedersen, Hans S. Poulsen

Cancer Res (2006) 66 (8_Supplement): 498.

Published: 15 April 2006

View article

Journal Articles

EGFRvIII is not degraded due to aberrant c-Cbl binding and transport to lysosomes

Michael V. Grandal, Roza Zandi, Mikkel W. Pedersen, Berthe M. Willumsen, Bo Van Deurs, Hans S. Poulsen

Cancer Res (2006) 66 (8_Supplement): 543.

Published: 15 April 2006

View article

Journal Articles

Ephrin receptor A2 binds to activated EGFR and modulates EGF induced cancer cell migration

Mikkel W. Pedersen, Alice Bjerregaard, Michael V. Grandal, Nina Pedersen, Bo Van Deurs, Hans S. Poulsen

Cancer Res (2006) 66 (8_Supplement): 772.

Published: 15 April 2006

View article

Journal Articles

Highly active, cancer specific promoters for gene therapy of small cell lung cancer

Nina Pedersen, Mikkel W. Pedersen, Michael S. Lan, Thomas T. Poulsen, Hans S. Poulsen

Cancer Res (2005) 65 (9_Supplement): 790–791.

Published: 01 May 2005

View article

Journal Articles

Characterization of novel therapeutic receptor target candidates for treatment of small cell lung cancer.

Thomas T. Poulsen, Nina Pedersen, Mikkel W. Pedersen, Hans S. Poulsen

Cancer Res (2004) 64 (7_Supplement): 708.

Published: 01 April 2004

View article

NARROW

Abstract 5310: Prognostic and predictive biomarkers of clinical response to Bevacizumab in recurrent WHO grade 3 malignant glioma patients

Abstract 4170: The role of VEGF-C for cell viability, tumor growth and bevacizumab resistance in glioblastoma multiforme

Abstract 3126: Insulinoma-associated 1 is a key transcriptional regulator of growth and survival-promoting pathways in small cell lung cancer.

Abstract 832: Suicide gene therapy is effective for treating chemo-resistant small cell lung cancer cells

Abstract 3701: Phase II study of BIBF1120 in recurrent glioblastoma multiforme

Abstract 2732: Internalization of the dual-specific immunotoxin D2C7-(scdsFv)-PE38KDEL in malignant glioma cell lines

Abstract 3339: The role of active Notch signaling in glioblastoma neurosphere cultures

EGFR and EGFRvIII induces expression of the proangiogenic receptor EphA2 in cancer cells

The human Achaete Scute Homolog 1 promoter - a candidate for transcriptionally regulated gene therapy of small cell lung cancer

EGFRvIII is not degraded due to aberrant c-Cbl binding and transport to lysosomes

Ephrin receptor A2 binds to activated EGFR and modulates EGF induced cancer cell migration

Highly active, cancer specific promoters for gene therapy of small cell lung cancer

Characterization of novel therapeutic receptor target candidates for treatment of small cell lung cancer.

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only